Analyze the phenotypes and endotypes of chronic rhinosinusitis with and without nasal polyps based on what is understood thus far about immunologic pathophysiology and its impact on disease burden
|
|
|
|
|
|
Summarize the mechanisms of action of new and emerging targeted biologics for CRSwNP, as well as the efficacy and safety profiles revealed in clinical trials
|
|
|
|
|
|
Implement shared decision making with CRSwNP patients to determine when a biologic, surgery, or other treatments are most appropriate
|
|
|
|
|
|